PropertyValue
?:abstract
  • The first cases of coronavirus 2019 (COVID-19) occurred in Wuhan, China, and rapidly become a public health emergency of international proportions. The disease may cause mild-to-severe acute respiratory syndrome (SARS) and is caused by a SARS-CoV-2 coronavirus infection. The clinical manifestations of COVID-19 include fever, dry cough, fatigue, sputum production, shortness of breath, sore throat, and headache. This article is a narrative review with the aim of analyzing the current literature on postviral olfactory dysfunction (OD) related to SARS-CoV-2 pandemics. Since the initial anecdotal reports from China, international reports on COVID-19 patients have been increasing, describing a 5% to 85% range of loss of smell. To date, the literature is widely heterogeneous regarding the loss of smell; therefore, we advise home isolation measures and/or social distancing, and to carry out diagnostic tests for SARS-CoV-2 when possible in those patients with sudden and severe loss of smell who cannot be promptly evaluated.
?:creator
?:doi
?:doi
  • 10.18176/jiaci.0567
?:journal
  • Journal_of_investigational_allergology_&_clinical_immunology
?:license
  • unk
?:pmid
?:pmid
  • 32406374
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • Olfactory dysfunction in the COVID-19 outbreak.
?:type
?:year
  • 2020-05-14

Metadata

Anon_0  
expand all